Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
Think I agree with that. I also believed this might be an investment where my heart and head could actually align, but it hasn't worked out that way. Neither is the product doing much good around the world (due to lack of deployment), nor is it making me money! In the recent Q1, FY24 Report, they say that they are seeking financing to see them through to "at least early calendar 2026". Two full years funding? Well, we shall see if that steep ambition is realised and at what cost to existing shareholders...
My losses are also so large it's not worth crystalising them, so I'm sticking it out.
A couple of weeks ago, Agricore wrote "Assuming a £10m raise at 16p per share that will equate to a 38% dilution. £15m is a 50% dilution. SED has support from a large number of IIs so the problem may actually be whether PIs even get a look in. As a PI, I will certainly be participating in any rights issue if I can". Not a bad guess, but in the end they were only able to raise £6.7m , albeit at a price of 17p. Even by their reckoning, that only buys us another 4 months. Either they're very certain about announcing transformative "major commercial developments" within that time frame before coming cap-in-hand again in March, or, more likely, £6.7m was all they could get.
Knife's edge. And maybe that's optimistic. My losses are so large it's not worth crystalising them, so I'm sticking it out.
Weird statement from our departing Chairman: "The scale of the opportunity for the Company remains significant and we remain confident that the NHS will rebound, survive and thrive once more, with the support of organisations such as Totally".
Er, not really. If the NHS were thriving there'd be no need for companies like Totally. It's the well-known problems and inefficiencies of the NHS that have brought the likes of us into their operations.
Put it this way. My investment thesis for this company did not depend on a thriving NHS. If that were true there would never be a good time to invest in Totally. My investment thesis depended on a struggling NHS - one that needed outside help and plenty of it.
So, I'm sorry Bob Holt, don't be disingenuous by blaming the NHS for Totally's travails. The blame is squarely with management and their failure to win/keep contracts at a growing and profitable rate. It's into the long grass for you Bob. If this was to be your swan song, it's not been a glorious one. A 'safe pair of hands' you were not.
All change. BOD becoming galvanised by the forthcoming continuation vote. Their jobs are at stake after all! Seems they have decided to facilitate a move by the managers away from the Jupiter umbrella and towards a new, independent entity. Personally, I think they should've taken this opportunity to reduce management fees further. Instead, apparently our managers require extra supervision... so charges increase by 5bps to fund "an enhanced risk process".
They say that "the reduction of various Jupiter-managed holdings in Chrysalis" is an issue which needs resolving. But then, in the rest of the RNS, they don't resolve it...
I might be reading too much into the article, but that is the first good news story involving boohoo that I can remember in... well... years. Should it signal a real change in the seemingly endless negative sentiment towards the company, it would make all the difference.
Shein, the fast fashion giant, is looking at setting up a new office in Manchester as part of its UK expansion. At first it will hire 15 staff for the new site, which will be on top of the 40 it already has on its books on London. The company's UK sales have boomed, rising to £1.1bn for the 16 months ending in December 2022. - The Financial Mail on Sunday
Sorry to see you go Paddyboy. Judging by today's further leg down, you did the right thing. Actually I bought more RENX shares yesterday so I'm probably that 'greater fool' you sold to. As you can imagine, I'm feeling a right chump about it today! On the other hand, I also bought more of sister company VRCI's shares and have just taken advantage of today's big rise in those shares by selling them for a 65% net profit over a 5 day holding period. These are the risks (and rewards) you take in the pre-profit biotech world. I'v put so much into RENX over the past year, and I'm so underwater, that I can't help but feel p*ssed off with myself.... That said, the VRCI story serves to remind that these things can turn on a sixpence. I think RENX will get funding, although no prediction on the terms. With the recent announcements of good inflation numbers on both sides of the pond, I'm sensing a definitive change in the investing climate. If I'm right, then at 20p, maybe, just maybe, the change in atmosphere hasn't yet been factored into RENX's share price.
Unbelievable. It's like the penny still hasn't dropped with management as to the dire financial position of their company. Revenue hasn't merely declined, it has actually *halved* from the equivalent quarter a year ago. Halved! How can that be? Revenues don't even cover the COGS anymore and that's before applying any of the still horribly large operating/admin expenses....
Management not exercised by the urgency of the situation - you'd almost think they had little skin in the game and felt their position was secure whatever fate befalls the company... oh, they haven't and it is!
We've all read about some of the hideously dilutive capital raises in the last couple of months - existing shareholders almost wiped out. Our turn next.
Couldn't agree more rotto. Sadly , 'deserve' doesn't come into it. No way can they sweep this under the carpet - if they don't publish a specific explanation now, they're going to have to explain what happened at the next scheduled reporting date.
Share price takes another leg down this morning.
To take advantage of the low price and indulge in a bit of 'bottom feeding' is to take a pure punt - one where the odds are probably stacked against you - I'm holding on and taking my losses but can't bring myself to throw good money after bad.
More board room shenanigans with today's announcement that the CFO has resigned 'with immediate effect'. Unlike Harry, she receives a terse thank you.
What to make of all this? Clearly there's been a board room bust-up. Has something gone wrong with the strategy? Are we about to receive bad operational news? Has someone been a naughty boy (or girl)? As usual, we PIs are left n the dark... left nursing our losses as the share price drops to all-time lows.